Overview

Detailed Summary

Quest Laboratories Limited specializes in the manufacturing of a wide range of pharmaceutical formulations, including ethical and generic drugs.
The company is experiencing rapid growth, evidenced by a 52% year-over-year increase in Q1FY26 revenues, thanks to expanded operations and product lines.
The development of their USFDA-compliant injectable facility targets both domestic and export markets, showcasing global ambitions in high-demand pharmaceutical segments.
Quest Laboratories leverages strategic government partnerships, participating in public sector tenders to secure large-scale orders, aiding its growth and market stability.
Its commitment to R&D and expanding manufacturing capabilities, including new investments in advanced injectables and capsules, positions the company for continued innovation and market penetration.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 162 Cr
Volatility: Low Risk
P/E Ratio: 10.8
Industry P/E: 33.7
PEG Ratio: 0.2
P/B Ratio: 1.7
52W High: 152.60
52W Low: 80.00

Sales CAGR

1Y: 25.93%
3Y: 20.46%
5Y: —
10Y: —

Profit CAGR

1Y: 34.49%
3Y: 48.95%
5Y: —
10Y: —

ROE

TTM: 15.51%
3Y: 22.86%
5Y: 23.66%
10Y: —

ROCE

TTM: 19.06%
3Y: 31.97%
5Y: 32.63%
10Y: —

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
QUESTLAB		101.15	166 Cr	11.04	1.71	0.00	15.51	19.06	13.51
NATCAPSUQ		157.00	163 Cr	-7.78	0.74	0.00	-7.27	-4.85	-5.82
KIMIABL		34.25	162 Cr	21.82	9.15	0.00	41.95	22.81	7.20
BMLL		128.60	162 Cr	12.05	2.61	0.00	66.48	47.70	0.00
PANCHSHEEL		120.15	160 Cr	14.78	1.14	0.00	7.69	9.73	6.30
ACHYUT		6.59	159 Cr	548.45	4.54	0.00	0.90	1.13	0.76
AUROLAB		253.00	158 Cr	91.91	3.68	0.00	4.47	7.31	1.55
Median: 7 Co.	—	120.15	162 Cr	14.78	2.61	0.00	7.69	9.73	1.55

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	15	27	15	46	23	26	31	32
Expenses	13	19	14	46	19	22	24	28
Operating Profit	1.78	8.80	0.67	0.81	3.81	3.39	6.90	4.13
OPM %	11.67	32.15	4.51	1.74	16.44	13.23	22.54	12.75
Other Income	0.16	0.68	0.30	3.41	1.85	1.42	0.57	-1.31
Interest	0.13	0.37	0.04	0.37	0.64	0.58	0.47	0.16
Depreciation	0.15	0.14	0.15	0.19	0.21	0.21	0.20	0.21
Profit Before Tax	1.66	8.97	0.78	3.67	4.82	4.02	6.80	2.46
Tax %	11.45	32.44	0.00	47.14	14.94	0.00	40.88	-16.67
Net Profit	1.48	6.06	0.78	1.94	4.10	4.02	4.03	2.87
EPS in Rs	—	—	—	1.18	—	2.45	2.46	1.74

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	30	59	62	83	104
Expenses	29	53	54	67	88
Operating Profit	1.42	6.47	7.84	16	16
OPM %	4.67	10.87	12.73	18.83	15.37
Other Income	0.07	0.06	0.23	0.23	4.24
Interest	0.31	0.30	0.54	0.76	0.91
Depreciation	0.39	0.46	0.55	0.57	0.64
Profit Before Tax	0.79	5.77	6.98	14	19
Tax %	17.04	28.82	27.74	30.13	27.39
Net Profit	0.66	4.11	5.04	10	14
EPS in Rs	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	1.08	1.08	1.08	12	16
Reserves	4.81	8.92	14	17	65
Borrowings	3.04	3.13	4.10	5.08	30
Other Liabilities	9.47	22	28	26	9.59
Total Liabilities	18	35	47	59	122
Fixed Assets	5.94	7.38	9.84	10	12
CWIP	0.00	0.00	0.00	0.00	0.00
Investments	0.09	0.09	0.09	0.09	52
Other Assets	12	27	37	49	58
Total Assets	18	35	47	59	122

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	1.05	3.46	3.88	3.01	-23
Cash from Investing Activity	-1.20	-1.89	-3.82	-5.03	-44
Cash from Financing Activity	0.04	-0.41	0.00	2.04	67
Net Cash Flow	-0.11	1.15	0.06	0.02	-0.03

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2024	May 2024	Mar 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	90.36%	65.83%	66.21%	66.78%	66.78%	66.78%
FIIs	0.00%	4.60%	0.95%	0.93%	0.61%	0.61%
DIIs	9.64%	7.10%	2.06%	1.39%	1.37%	2.04%
Public	0.00%	22.47%	30.77%	30.89%	31.24%	30.56%
Total Shareholders	20	1,732	1,001	1,084	1,017	911

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q2 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.